Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT06649006 · COMPLETED
Trial details
- NCT number
- NCT06649006
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2025-07-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.